Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Deputy Commissioner for Policy

This article was originally published in The Gray Sheet

Executive Summary

William Schultz, previously legal counsel for the House Energy and Commerce/Health Subcommittee, is in line to fill the position following the departure of former deputy commissioner Michael Taylor to the Department of Agriculture ("The Gray Sheet" Aug. 1, In Brief). Schultz began serving as a consultant in FDA's Office of the Commissioner beginning the week of Nov. 21. Schultz joined the Energy and Commerce staff in January 1990 ("The Gray Sheet" Dec. 14, 1989, p. 17) and became Subcommittee Chairman Henry Waxman's (D-Calif.) chief aide on medical device and drug issues. Prior to his tenure on the Hill, Schultz was legal counsel for 14 years for Public Citizen's Health Research Group
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003145

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel